EPINEPHRINE DERIVATES AND THE ACTIVITY OF THE HUMAN UTERUS. I. . THE INHIBITING EFFECT OF P-HYDROXYPHENYLISOPROPYLARTERENOL (CC-25) UPON UTERINE ACTIVITY IN HUMAN PREGNANCY.
D000033:Abortion, Threatened; D004358:Drug Therapy; D004837:Epinephrine; D004874:Ergonovine; D004983:Ethanolamines; D005260:Female; D005313:Fetal Death; D006801:Humans; D007751:Labor, Induced; D007743:Labor, Obstetric; D009638:Norepinephrine / Q000031:analogs & derivatives; D007752:Obstetric Labor, Premature; D010121:Oxytocin; D010600:Pharmacology; D006831:Polyhydramnios; D011225:Pre-Eclampsia; D011247:Pregnancy; D013565:Sympatholytics; D013566:Sympathomimetics; D014116:Toxicology; D014599:Uterus; D014665:Vasodilator Agents
D004983:Ethanolamines; D013565:Sympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents; C001417:4-hydroxyphenylisopropylarterenol; D010121:Oxytocin; D004874:Ergonovine; D009638:Norepinephrine; C084832:pronethalol; D004837:Epinephrine
ABORTION, THREATENED; DRUG THERAPY; ERGONOVINE; FETAL DEATH; HYDRAMNIOS; LABOR, INDUCED; LABOR, PREMATURE; OXYTOCIN; PHARMACOLOGY; PREGNANCY; PREGNANCY TOXEMIAS; PRONETHALOL; SYMPATHOLYTICS; SYMPATHOMIMETICS; TOXICOLOGIC REPORT; UTERUS; VASODILATOR AGENTS